Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04334135 · ClinicalTrials.gov registry record · NA

The Influence of Mitochondrial-Derived Reactive Oxygen Species on Racial Disparities in Neurovascular Function

A NA study of Blood Pressure and Cardiovascular Risk Factor, sponsored by Auburn University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT04334135 is a NA study of Blood Pressure and Cardiovascular Risk Factor that is actively recruiting participants, run by Auburn University. The registered enrollment target is 60 participants, below the 286-participant average among 101 other Blood Pressure trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04334135, a NA study of Blood Pressure and Cardiovascular Risk Factor, is actively recruiting participants, sponsored by Auburn University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Black individuals are at increased cardiovascular disease risk. The central goal of the study is to determine if mitochondrial reactive oxygen species influence blood vessel function and nervous system regulation of blood pressure differentially in black, compared to white individuals. These findings may help to explain a potential mechanism that contributes to racial disparities in blood pressure and cardiovascular disease risk. A secondary goal is to determine if mitochondrial reactive oxygen species improves blood pressure and vascular function in individuals with elevated blood pressure and stage 1 hypertension.

Interventions

  • DIETARY_SUPPLEMENT MitoQ

Study Locations (1)

Alabama

  • Kinesiology Building - Auburn

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2020-10-02
Est. Completion 2025-08-31
Phase NA

Sponsor

Auburn University

54 total trials

What the Registry Record Tells You About NCT04334135

The ClinicalTrials.gov registry entry for NCT04334135 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 286-participant average among 101 other Blood Pressure trials with a reported enrollment target (79% lower). The listed sponsor is Auburn University, which has 54 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Blood Pressure appearing as the primary indexed condition, and to 1 intervention - of which MitoQ is the first listed.

NCT04334135 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT04334135 about?

NCT04334135 is a clinical study titled "The Influence of Mitochondrial-Derived Reactive Oxygen Species on Racial Disparities in Neurovascular Function". Black individuals are at increased cardiovascular disease risk. The central goal of the study is to determine if mitochondrial reactive oxygen species influence blood vessel function and nervous system regulation of blood pressure differentially in black, compared to white individuals. These finding...

What is the current status of trial NCT04334135?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2020-10-02. Estimated completion is 2025-08-31.

What conditions does trial NCT04334135 study?

This clinical trial studies the following conditions: Blood Pressure, Cardiovascular Risk Factor, Racial Disparities, Renal Function.

What interventions are being tested in trial NCT04334135?

The interventions under investigation include: MitoQ (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04334135?

This trial is sponsored by Auburn University, which has 54 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04334135 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Blood Pressure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.